Johannes Bischof

Salzburg, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.

Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosa.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 25, 2025

Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models.

Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models.

Journal: Cell stem cell

Published: April 03, 2025

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.

Journal: International journal of molecular sciences

Published: December 21, 2023

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: December 01, 2023

On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.

On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: August 30, 2023

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.

MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.

Journal: The British journal of dermatology

Published: March 21, 2023

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.

Journal: International journal of molecular sciences

Published: February 07, 2023

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.

Journal: Cancers

Published: January 05, 2023

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.

COL7A1 Editing via RNA Trans-Splicing in RDEB-Derived Skin Equivalents.

Journal: International journal of molecular sciences

Published: December 21, 2022

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.

COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa.

Journal: Frontiers in medicine

Published: June 23, 2022

Current developments in gene therapy for epidermolysis bullosa.

Current developments in gene therapy for epidermolysis bullosa.

Journal: Expert opinion on biological therapy

Published: March 02, 2022

The Role of EAAT4 in Epidermal Differentiation and Calcium Homeostasis during Aging.

The Role of EAAT4 in Epidermal Differentiation and Calcium Homeostasis during Aging.

Journal: The Journal of investigative dermatology

Published: February 16, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026